KALARIS THERAPEUTICS, INC. (KLRS) Operating income 2019–2025
KALARIS THERAPEUTICS, INC. (KLRS) annual operating income history from SEC filings — each fiscal year as reported.
-$46.2MFY2025 · since FY2019: -$26.7M → -$46.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$46.2M | +10.8% |
| FY2024 | -$51.7M | +74.1% |
| FY2023 | -$199.9M | -16.8% |
| FY2022 | -$171.2M | -0.8% |
| FY2021 | -$169.8M | -138.1% |
| FY2020 | -$71.3M | -167.1% |
| FY2019 | -$26.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KLRS financial trends
KLRS RevenueKLRS Net incomeKLRS Net marginKLRS Gross profitKLRS Gross marginKLRS Operating marginKLRS Operating cash flowKLRS Free cash flowKLRS Capital expendituresKLRS Return on equityKLRS Stock buybacksKLRS Dividends paidKLRS Total assetsKLRS Total liabilitiesKLRS Shareholders’ equityKLRS overview →